Research graph

References

References from La rispéridone injectable à libération prolongée : enquête d’utilisation dans trois établissements d’Aquitaine. Local targets link to admitted publications; unresolved targets remain external evidence.

Unresolved reference

External reference

Unresolved reference

External reference

Intramuscular preparations of antipsychotics: uses and relevance in clinical practice

10.2165/00003495-200363050-00004 · 2003 · External reference

Unresolved reference

External reference

Depot antipsychotic drugs: place in therapy

10.2165/00003495-199447050-00004 · 1994 · External reference

Treatment of schizophrenia with long-acting injectable rispéridone: a 12-month open-label trial of the first long-acting second-generation antipsychotic

10.4088/jcp.v64n1017 · 2003 · External reference

Tableau d’évaluation assistée de la qualité de vie (TEAQV)

1996 · External reference

10.1037/e591322011-001

10.1037/e591322011-001 · External reference

Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies

2003 · External reference

Long-acting injectable rispéridone: efficacy and safety of the first long-acting atypical antipsychotic

10.1176/appi.ajp.160.6.1125 · 2003 · External reference

The positive and negative syndrome scale (PANSS) for schizophrenia

10.1093/schbul/13.2.261 · 1987 · External reference

Efficience des antipsychotiques chez les patients atteints de schizophrénie chronique

10.1056/nejmoa051688 · 2005 · External reference

Overview of partial compliance

2003 · External reference

Unresolved reference

External reference

Relapse and rehospitalization: comparing oral and depot antipsychotics

2003 · External reference

Adherence assessments and the use of depot antipsychotics in patients with schizophrenia

10.4088/jcp.v62n07a08 · 2001 · External reference